Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertility Preservation | 7 | 2023 | 53 | 3.020 |
Why?
|
| Ovarian Reserve | 3 | 2023 | 11 | 1.250 |
Why?
|
| Infertility, Female | 3 | 2023 | 144 | 1.020 |
Why?
|
| Doxorubicin | 2 | 2023 | 288 | 0.940 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2023 | 37 | 0.940 |
Why?
|
| Infertility, Male | 2 | 2022 | 279 | 0.800 |
Why?
|
| Semen Preservation | 1 | 2022 | 9 | 0.790 |
Why?
|
| Neoplasms | 3 | 2023 | 2790 | 0.640 |
Why?
|
| Directive Counseling | 1 | 2019 | 24 | 0.630 |
Why?
|
| Counseling | 1 | 2020 | 220 | 0.610 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 1245 | 0.550 |
Why?
|
| Cryopreservation | 5 | 2022 | 73 | 0.550 |
Why?
|
| Fertilization in Vitro | 5 | 2024 | 156 | 0.540 |
Why?
|
| Patient Selection | 1 | 2020 | 693 | 0.530 |
Why?
|
| Ovulation Induction | 4 | 2024 | 41 | 0.500 |
Why?
|
| Preimplantation Diagnosis | 3 | 2014 | 24 | 0.460 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 2516 | 0.420 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 576 | 0.420 |
Why?
|
| Granulosa Cells | 3 | 2022 | 133 | 0.330 |
Why?
|
| Cyclophosphamide | 2 | 2023 | 412 | 0.330 |
Why?
|
| Pregnancy | 14 | 2024 | 7215 | 0.310 |
Why?
|
| Oocytes | 3 | 2019 | 298 | 0.290 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2020 | 236 | 0.270 |
Why?
|
| Female | 23 | 2024 | 66669 | 0.250 |
Why?
|
| Blastocyst | 2 | 2013 | 76 | 0.250 |
Why?
|
| Sperm Injections, Intracytoplasmic | 2 | 2013 | 44 | 0.250 |
Why?
|
| Pregnancy, Ectopic | 1 | 2005 | 23 | 0.240 |
Why?
|
| Uterine Perforation | 1 | 2004 | 1 | 0.230 |
Why?
|
| Hysterosalpingography | 1 | 2004 | 5 | 0.230 |
Why?
|
| Chromosomes | 1 | 2004 | 162 | 0.220 |
Why?
|
| Aneuploidy | 1 | 2004 | 142 | 0.220 |
Why?
|
| Methotrexate | 1 | 2005 | 336 | 0.210 |
Why?
|
| Paclitaxel | 1 | 2023 | 127 | 0.210 |
Why?
|
| Endometrial Neoplasms | 2 | 2020 | 99 | 0.200 |
Why?
|
| Humans | 24 | 2024 | 125025 | 0.200 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 454 | 0.200 |
Why?
|
| Cell Nucleus | 1 | 2004 | 664 | 0.190 |
Why?
|
| Adult | 14 | 2024 | 29452 | 0.190 |
Why?
|
| Ovarian Diseases | 1 | 2021 | 28 | 0.190 |
Why?
|
| Translocation, Genetic | 1 | 2003 | 357 | 0.180 |
Why?
|
| Fertility | 1 | 2023 | 257 | 0.170 |
Why?
|
| Young Adult | 3 | 2023 | 9054 | 0.170 |
Why?
|
| Conservative Treatment | 1 | 2020 | 36 | 0.170 |
Why?
|
| Premenopause | 1 | 2020 | 31 | 0.170 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2020 | 62 | 0.170 |
Why?
|
| Uterus | 1 | 2024 | 567 | 0.170 |
Why?
|
| Gene Expression | 1 | 2004 | 1550 | 0.160 |
Why?
|
| Ultrasonography | 1 | 2024 | 938 | 0.160 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2020 | 51 | 0.160 |
Why?
|
| Vincristine | 1 | 2020 | 191 | 0.160 |
Why?
|
| Vaccination | 1 | 2023 | 961 | 0.140 |
Why?
|
| Estrogens | 1 | 2020 | 503 | 0.140 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 220 | 0.140 |
Why?
|
| Embryo Transfer | 3 | 2024 | 58 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 420 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 470 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2024 | 16334 | 0.130 |
Why?
|
| BRCA2 Protein | 1 | 2014 | 45 | 0.110 |
Why?
|
| BRCA1 Protein | 1 | 2014 | 71 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2004 | 769 | 0.100 |
Why?
|
| Obesity | 1 | 2020 | 2244 | 0.080 |
Why?
|
| Oogenesis | 1 | 2008 | 56 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 3402 | 0.070 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2008 | 73 | 0.070 |
Why?
|
| Middle Aged | 3 | 2023 | 26670 | 0.070 |
Why?
|
| Menstrual Cycle | 1 | 2005 | 34 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2024 | 4819 | 0.060 |
Why?
|
| Male | 4 | 2022 | 61429 | 0.060 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 131 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2005 | 394 | 0.060 |
Why?
|
| Hyaluronan Synthases | 1 | 2004 | 11 | 0.060 |
Why?
|
| Serum Amyloid P-Component | 1 | 2004 | 14 | 0.060 |
Why?
|
| Blastomeres | 1 | 2004 | 6 | 0.060 |
Why?
|
| Pregnancy Outcome | 2 | 2005 | 596 | 0.060 |
Why?
|
| Pregnancy Rate | 1 | 2004 | 37 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2005 | 335 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 83 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 68 | 0.060 |
Why?
|
| Sperm Motility | 1 | 2004 | 101 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 155 | 0.050 |
Why?
|
| Live Birth | 1 | 2023 | 55 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2005 | 233 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2003 | 119 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 283 | 0.050 |
Why?
|
| Acceleration | 1 | 2022 | 26 | 0.050 |
Why?
|
| ROC Curve | 1 | 2004 | 571 | 0.050 |
Why?
|
| Spermatozoa | 1 | 2004 | 231 | 0.050 |
Why?
|
| Follicular Fluid | 1 | 2021 | 7 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 434 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2003 | 372 | 0.050 |
Why?
|
| Wound Healing | 1 | 2004 | 457 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2004 | 490 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 2181 | 0.040 |
Why?
|
| Age Distribution | 1 | 2019 | 418 | 0.040 |
Why?
|
| Endometrium | 1 | 2020 | 280 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 3674 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1538 | 0.030 |
Why?
|
| Biomarkers | 2 | 2020 | 3105 | 0.030 |
Why?
|
| Cytokines | 1 | 2021 | 1292 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3310 | 0.030 |
Why?
|
| United States | 2 | 2020 | 10884 | 0.030 |
Why?
|
| Reproductive Behavior | 1 | 2013 | 7 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2013 | 136 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2004 | 8272 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 19412 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2014 | 1016 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 819 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 10278 | 0.020 |
Why?
|
| Texas | 1 | 2013 | 3571 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 433 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 584 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 3175 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 19653 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 5897 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 2458 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 34205 | 0.000 |
Why?
|